Page last updated: 2024-11-12

pentaborane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID15764013
MeSH IDM0123273

Synonyms (15)

Synonym
BIDD:ER0069
pentaborane
19624-22-7
65580-80-5
(-)-epn
unii-3qp6ts3ga2
ethyl p-nitrophenyl benzenethiophosphonate, (-)-
phosphonothioic acid, phenyl-, o-ethyl o-(4-nitrophenyl) ester, (-)-
3qp6ts3ga2 ,
phosphonothioic acid, phenyl-, o-ethyl o-(4-nitrophenyl) ester, (s)-
phosphonothioic acid, p-phenyl-, o-ethyl o-(4-nitrophenyl) ester, (p(s))-
phosphonothioic acid, phenyl-, o-ethyl o-(4-nitrophenyl) ester, (p(s))-
(-)-ethyl p-nitrophenyl benzenethiophosphonate
Q27257910
ethoxy-(4-nitrophenoxy)-phenyl-sulfanylidene-lambda5-phosphane

Research Excerpts

Overview

Pentaborane is an extremely toxic compound and a major hazard not only to exposed workers but also to the medical personnel dealing with them.

ExcerptReferenceRelevance
"Pentaborane is an extremely toxic compound and a major hazard not only to exposed workers but also to the medical personnel dealing with them."( Severe central nervous system damage and profound acidosis in persons exposed to pentaborane.
Cooper, KR; Garrettson, LK; Kelleher, AB; Steele, MH; Yarbrough, BE; Zolet, DI,
)
1.08
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-199017 (89.47)18.7374
1990's0 (0.00)18.2507
2000's2 (10.53)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.42 (24.57)
Research Supply Index3.04 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index53.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.00%)6.00%
Case Studies1 (5.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (90.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]